Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results


1.		Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care				Completed				18 and over				Other				METC 191.137/2000/088 NCT00263315

Last Modified: 11/1/1995


2.		Phase III Randomized, Double-Blind Study of Liposomal Amphotericin B vs Standard Formulation Amphotericin B for Empiric Treatment of Persistent Febrile Neutropenia Unresponsive to Broad Spectrum Antibacterial Agents (Summary Last Modified 11/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				2 to 80				NCI				NCI-95-C-0131A

Last Modified: 9/1/1999 First Published: 5/1/1998


3.		Phase III Randomized Study of Voriconazole Compared to Liposomal Amphotericin B as Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia (Summary Last Modified 09/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				12 and over				NCI, Pharmaceutical / Industry				NCI-98-C-0063 PFIZER-150-603

Last Modified: 5/21/2007 First Published: 6/1/1998


4.		Phase III Randomized Study of Liposomal Amphotericin B with or without Sargramostim in Patients with Invasive Fungal Infections Entered into Protocols MRC-LEUK-AML11, AML12, or UKALLXII (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				15 and over								MRC-LEUK-IFI EU-97030, NCT00003315

Last Modified: 7/11/2007 First Published: 8/1/1999


5.		Phase III Randomized Study of Amphotericin B-Liposomal Formulation Initiated 72-84 Hours vs 144-156 Hours After Onset of a Febrile Episode in Cancer Patients With Granulocytopenia and Persistent Unexplained Fever Refractory to Antibacterials

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				Not specified				Other				EORTC-19951 NCT00003938

Last Modified: 7/11/2007 First Published: 1/1/2001


6.		Phase III Randomized Study of Caspofungin Acetate Versus Amphotericin B Liposomal in Patients With Persistent Fever and Neutropenia Following Treatment for Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				16 and over				NCI, Pharmaceutical / Industry				MSKCC-00085 MERCK-026-01, NCI-G00-1898, NCT00008359

Last Modified: 1/1/1998


7.		Phase I/II Study of Amphotericin B-Lipid Complex (AmBisome) in Immunocompromised Pediatric Patients with Definitive or Probable Invasive Fungal Infection (Summary Last Modified 01/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care				Closed				1 to 17				NCI				NCI-97-C-0013

Last Modified: 9/1/1995


8.		Phase I/II Pilot Study of Amphotericin-B Lipid Complex in the Treatment of Hepatosplenic Candidiasis in Children with Neoplastic Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care				Completed				2 to 18				NCI				NCI-92-C-0047B NCI-T92-0001N, T92-0001


9.		MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				2 to 17				Pharmaceutical / Industry				2004_101 Formerly-0404ETPP, MK0991-044, NCT00082537

Last Modified: 7/1/1995


10.		Phase I Study of Liposomal Amphotericin B in Adult Cancer Patients Receiving Antineoplastic Therapy or Bone Marrow Transplantation (Summary Last Modified 07/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Supportive care				Completed				13 to 80								NCI-94-C-0120D

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute